期刊文献+

急性冠状动脉综合征患者血浆IL-18结合蛋白和IL-18水平变化及意义 被引量:6

Elevated plasma IL-18 binding protein and IL-18 levels in patients with acute coronary syndrome
原文传递
导出
摘要 目的:探讨急性冠状动脉综合征(ACS)患者血浆白细胞介素(IL)-18结合蛋白和IL-18水平的变化。方法:连续入选稳定型心绞痛(SAP)组(50例),不稳定型心绞痛(UAP)组(75例)和急性心肌梗死(AMI)组(67例)。同期冠状动脉(冠脉)造影正常的65例患者为对照组。采用夹心酶联免疫法(ELISA)测定血浆IL-18结合蛋白和IL-18水平。结果:SAP组、UAP组和AMI组血浆IL-18和IL-18结合蛋白水平显著高于对照组,UAP组和AMI组血浆IL-18和IL-18结合蛋白水平显著高于SAP组。冠心病患者IL-18结合蛋白水平与IL-18、C反应蛋白(CRP)、左室舒张末期内径(LVEDD)正相关,与左室射血分数(LVEF)显著负相关。结论:血浆IL-18结合蛋白和IL-18水平变化可能与ACS的出现密切相关。 Objective:To evaluate the levels of IL-18 binding protein and IL-18 in patients with acute coronary syndrome(ACS).Method:The plasma IL-18 binding protein and IL-18 levels were measured in 50 patients with stable angina pectoris(SAP),75 patients with unstable angina pectoris(UAP),67 patients with acute myocardial infarction(AMI)and 65 control patients.Result:The plasma IL-18 binding protein and IL-18 levels were significantly higher in the AMI,SAP and UAP groups than in the control group.And plasma IL-18 binding protein and IL-18 levels were significantly higher in the AMI and UAP groups than in the SAP group.A correlation analysis showed that the plasma IL-18 binding protein levels were positively correlated with IL-18,CRP and LVEDD,but negatively correlated with LVEF.Conclusion:The results indicate that the plasma IL-18 binding protein and IL-18 levels are associated with the onset of ACS symptoms.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2015年第1期23-26,共4页 Journal of Clinical Cardiology
关键词 急性冠状动脉综合征 白细胞介素-18结合蛋白 白细胞介素-18 炎症 acute coronary syndrome interleukin-18binding protein interleukin-18 inflammation
  • 相关文献

参考文献2

二级参考文献30

  • 1萨京,曾秋棠,王祥,郭和平.Th1/Th2细胞失衡在不稳定型心绞痛发病机制中的作用[J].临床心血管病杂志,2005,21(10):588-590. 被引量:7
  • 2胡英锋,李大主,杨克平,曾秋棠,李裕舒,王祥,冯义柏,曹林生.急性冠脉综合征患者外周血中CD4^+ CD25^+调节性T细胞的检测及意义[J].免疫学杂志,2007,23(4):433-435. 被引量:11
  • 3COI.I.ISON I. W, WORKMAN C J, KUOT T, et al. The inhibitory eytokine II.-35 contributes to regulatory T cell funetion[J]. Nature,2007,450:566- 569.
  • 4CHATURVEDI V, COLI.ISON L W, GUY C S, et al. Cutting edge: Human regulatory T cells require IL-35 lo mediate suppression and infectious tolerance [J]. lmmunol,2011,186:6661-6666.
  • 5NIEDBALAW, WEI X Q, CAI B, et al. IL35 is a novel cytokine with lherapeutic effects against colla-gen-induced arthritis through the expansion of regula- tory T cells and suppression of Thl7 cells[J].Eur J Immunol, 2007,37 : 3021 - 3029.
  • 6WIRTZ S, BILI.MEIER U, MCHEDLIDZE T, et al. Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis[J]. Gas troenterology, 2011,141 : 1875 - 1886.
  • 7HUANG C H, LOO E X, KUO I C, et al. Airway inflammation and IgE production induced by dust mile allergen-specific memory/effector Th2 cell line can be effectively attenuated by IL-35 [J].J Immunol, 2011, 187:462-471.
  • 8ZANDIAN M, MOTT K R, AI.LEN S J, et al. Use of cytokine immunotherapy to block CNS demyelina- tion induced by a recombinant HSV-1 expressing II.-2 [J].GeneTher,2011,18:734-742.
  • 9MAI.LAT Z, AIT-OUFELI.A H, TEDGUI A. Reg ulatory T-cell immunity in atherosclerosis[J]. Trends Cardiovasc Med.2007,17:l13- 118.
  • 10EID R E, RAO D A, ZHOU J, et al. Interleukin 17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act syn- ergistically on vascular smooth muscle cells[J].Cit culation, 2009,119 " 1424-1432.

共引文献18

同被引文献73

引证文献6

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部